# Quality of Life, Symptoms and Treatment Satisfaction in Adult Patients With Relapsed and/or Refractory Multiple Myeloma, Receiving Ixazomib (Ninlaro®) in Combination With Lenalidomide and Dexamethasone in a Real World Setting: Pilot Study

> **NCT03903406** · — · UNKNOWN · sponsor: **Multinational Center for Quality of Life Research, Russia** · enrollment: 40 (estimated)

## Conditions studied

- Relapsed and/or Refractory Multiple Myeloma

## Interventions

- **DRUG:** ixazomib in combination with lenalidomide and dexamethasone

## Key facts

- **NCT ID:** NCT03903406
- **Lead sponsor:** Multinational Center for Quality of Life Research, Russia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05
- **Primary completion:** 2021-11
- **Final completion:** 2021-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03903406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03903406, "Quality of Life, Symptoms and Treatment Satisfaction in Adult Patients With Relapsed and/or Refractory Multiple Myeloma, Receiving Ixazomib (Ninlaro®) in Combination With Lenalidomide and Dexamethasone in a Real World Setting: Pilot Study". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03903406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*